PHARMACOLOGICAL TEST SYSTEMS

Furthermore, the affinities of the a2-adrenoceptor antagonists atipamezole and yohimbine are nearly indistinguishable (atipamezole human a2-Cl 0 Kj = 2.9 0.4 nM, mouse a2-4H Ki = 1.6 0.2 nM yohimbine human a2-Cl 0 = 

Such complex end points are difficult to predict from any one of the component processes leading to yet another leap of faith in the drug discovery process. For these reasons, an emerging strategy for drug discovery is the use of natural cellular systems. This approach is discussed in some detail in Chapter 8. 

---

Characterisation of the structure and conformation of small biologically active molecules is part of the standard approach to lead generation in drug design studies. In particular, it is now possible to automatically synthesise many thousands of small molecules and then rapidly measure their effects in a given pharmacological test system. The power of such techniques comes from the immense number of compounds which can be generated and screened for activity. Two studies have evaluated HPLC-NMR in the field, one based on a mixture of 27 closely related tripeptides [24] and the other on two separate mixtures of four aromatic compounds and three pentapeptides [25]. 

Authors are designed row sensitive and selective test-systems for analysis of heavy metals, active chlorine, phenols, nitrates, nitrites, phosphate etc. for analysis of objects of an environment and for control of ions Ee contents in the technological solutions of KH PO, as well as for testing some of pharmacological psychotropic daigs alkaloids (including opiates), cannabis as well as pharmaceutical preparations of phenothiazines, barbiturates and 1,4-benzodiazepines series too. 

A small group of polycyclic compounds defy ready classification on a chemical or, for that matter, pharmacological basis. It must be assumed that they showed enough promise in various experimental test systems to be at least considered for clinical trials. Though few of these seem to have been commercialized as a dmg, their preparation nonetheless presents interesting chemistry. 

Behavioral and Pharmacological Tests. Behavioral and pharmacological tests involve the observation of clinical signs and behavior. These include signs of changes in awareness, mood, motor activity, central nervous system excitation, posture, motor incoordination, muscle tone, reflexes, and autonomic functions. If these tests so indicate, more specialized tests can be carried out that evaluate spontaneous motor activity, conditioned avoidance responses, operant conditioning, as well as tests for motor incoordination such as the inclined plane or rotarod tests. 

Eglin c has been extensively studied in a number of pharmacological and toxicological test systems, Eglin c showed effectiveness in preventing... 

Among the substances which are described here, the polymers have only a vehicle function or they represent the deposit form. Besides the above-described polymeric N-oxides and plasma substitutes further water-soluble nontoxic polymers, such as polymers from 2-hydroxyethyl acrylate or methacrylate (71), alkylsulfinyl acrylates and methacrylates (72), diethoxyethylenes (73), and other substances as yet pharmacologically tested, are in question. Differentiation, however, can be between preparations, whose active substance has to be split off - a fact which has to be taken for granted in the case of substances that are active in the central nervous system -and substances that are still active at the polymeric carrier. Only recently it has been shown by Kaplan (74, 75) that this is possible, at least in such cases where an activity is to be supposed via receptors in the cell membrane. In many other cases this question cannot be cleared up unequivocally. 

---